TRINA BIOREACTIVES

What TRINA BIOREACTIVES does

TRINA Bioreactives AG is a Swiss-domiciled (Nänikon, Switzerland) manufacturer and procurement partner of biological raw materials for the in vitro diagnostics (IVD) industry, founded in 1994 and operating for over 30 years. The company supplies human biospecimens — plasma, serum, disease-state plasma, clinical specimens, antigens, antibodies, cell culture products, and quality controls/calibrators — to the global Top 20 IVD manufacturers for use in assay development, quality control, and production. Its catalog spans approximately 1,856 SKUs (including 268 Serum & Plasma, 773 Disease State Plasma, 253 Clinical Specimen, and 562 Antigens & Antibodies products), supported by a Swiss manufacturing operation under ISO 13485:2016 certification and an inventory vault storing over 25,000 probes and bottles representing 1,300,000+ liters of plasma production capacity.

The business model is sales-led and quote-based, with pricing not publicly disclosed; revenues are generated primarily through one-time catalog sales of biospecimens and complementary custom collection and processing services. Distribution is executed through a dedicated Global Sales channel, a regional Asia Sales channel, and a worldwide network of manufacturing partners and joint-ventures, enabling deliveries to over 40 countries. Customers are exclusively enterprise IVD manufacturers requiring FDA- and EU Directive-compliant, ethically sourced raw materials, with custom specimen collection and testing on specially designed equipment positioned as the principal value-add.

Operationally, the company is privately held, lean (11-50 employees), and led by Managing Director/CEO Adrian Jencik. There is no evidence of external institutional investment, M&A activity, public listing, or recent leadership turnover. The firm runs an SQS- and IQNet-certified quality management system and is registered as TRINA BIOREACTIVES AG in Switzerland. End-markets served are IVD assay R&D, manufacturing scale-up, and quality control laboratories within the diagnostics value chain.

Name

TRINA BIOREACTIVES

Legal name

TRINA BIOREACTIVES AG

Website

https://trinabio.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

11–50 employees

Short description

TRINA Bioreactives AG is a Swiss manufacturer and sourcing partner supplying human biospecimens (plasma, serum, disease-state plasma, antigens, antibodies, cell culture products, and controls) to the global Top 20 IVD companies across 40+ countries, operating under ISO 13485:2016 certification.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics Raw Materials

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers) (HLAGAIAG)

akta.pro secondary industry

Biologics & Biosimilars Distributors (HLAIAJAH)

Keywords

• In vitro diagnostics raw materials
• Human biospecimens supply
• Diagnostic antigens antibodies
• IVD quality control materials
• Cell culture supplements

Headquarters

HQ city

Nänikon

HQ country

Switzerland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Biospecimen Sales: Sale of human plasma, serum, disease-state plasma, clinical specimens, and patient samples to IVD manufacturers for assay development, quality control, and manufacturing
2. Antigens and Antibodies: Sale of antigens and antibodies for diagnostic assay development and manufacturing
3. Cell Culture Products: Sale of cell culture products including human AB converted serum, platelet lysate, serum albumin, transferrin, and recombinant insulin
4. Controls and Calibrators: Sale of quality control materials including ASO RF CRP Control, Cardiac Marker Control, Clinical Chemistry Control, HbA1c Linearity Control, Immunoassay Control, Lipid Control, and TORCH Control
5. Custom Collection Services: Customized specimen collection and processing services tailored to customer specifications

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

TRINA Bioreactives manufactures and procures human biospecimens and biological raw materials — including serum, plasma, disease-state specimens, antigens, antibodies, cell culture products, and clinical diagnostic controls — for the global Top 20 IVD Companies. Operations are anchored in ISO 13485:2016 Swiss manufacturing, an extensive in-house biobank vault, and a worldwide partner network that supports customer-specified development, special screening, and customized collection services.

Product overview

TRINA Bioreactives is a Swiss sourcing and manufacturing partner supplying the global Top 20 IVD companies with biological raw materials for in vitro diagnostics. The company operates as a unified product portfolio organized around six core product categories: Serum & Plasma Products (off-the-clot, processed, animal serum, plasma components), Disease State Plasma (allergy, autoimmune, hepatitis, virus, coagulation, bacteria specimens), Clinical Specimen (patient samples, customized collections, isolated cell lines), Antigens & Antibodies (for autoimmune, cancer, cardiac, coagulation applications), Cell Culture Products (Human AB Converted Serum, Human Platelet Lysate, Human Serum Albumin, Human Transferrin HOLO, Recombinant Human Insulin), and Controls & Calibrators (ASO RF CRP, Cardiac Marker, Clinical Chemistry, HbA1c, Immunoassay, Lipid, TORCH controls). With over 30 years of experience, TRINA manufactures in Switzerland through a worldwide sustainable network of partners and joint-ventures, specializing in customer-specified requirements including development, special screening, securing raw materials, and testing.

Differentiator

Problem solved

Functional benefit

Products and services

• Serum & Plasma Products Comprehensive range of human and animal serum and plasma products including off-the-clot serum, processed serum (affinity stripped, charcoal stripped, basematrix), and plasma components with custom anticoagulants, supplied to IVD manufacturers for assay development and quality control.
• Disease State Plasma Positive plasma and off-the-clot serum specimens for IVD assay development, quality control, and manufacturing, covering allergy, autoimmune, hepatitis, virus, coagulation, and bacterial conditions.
• Clinical Specimen Products Human biospecimens from healthy donors and those with specific clinical conditions, including customized biospecimen panels for IVD research, development, and testing, available in serum, plasma, matched sets, or panels.
• Antigens & Antibodies Extensive portfolio of antigens and antibodies for autoimmune, cancer/tumor, cardiac, coagulation, endocrine, enzyme, infectious, and hepatitis applications, used in diagnostic assay development and manufacturing.
• Cell Culture Products Cell culture supplements including Human AB Converted Serum, Animal Serum, Human Platelet Lysate, Human Serum Albumin, Human Transferrin HOLO, and Recombinant Human Insulin for IVD and bioprocessing applications.
• Controls & Calibrators Quality control materials including ASO RF CRP Control, Cardiac Marker Control, Clinical Chemistry Control, HbA1c Linearity Control, Immunoassay Control, Lipid Control, and TORCH Control for IVD manufacturing and quality assurance.
• Coagulation Factor Products Specialized coagulation-deficient plasma products including factors I through XIII, fibrinogen, protein C/S, von Willebrand factor, and lupus anticoagulant for coagulation testing and research.
• Custom Collection and Processing Services Customized specimen collection and processing services tailored to customer specifications, including special screening, securing of raw materials, and testing on specially designed equipment for IVD manufacturers.

Quantifiable outcome

• 1,300,000 liters of plasma produced
• +3 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Worldwide Partners and Joint-VenturescoreOthersTRINA Bioreactives supplements their Swiss manufacturing through a worldwide sustainable network of partners and joint-ventures, enabling global reach and diversified sourcing capabilities for IVD biospecimens and raw materials.

Scale indicators6 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• SeraCare (LGC Clinical Diagnostics): SeraCare is a leading supplier of IVD controls, calibrators, and reference materials - directly comparable to TRINA's Controls & Calibrators business serving Top 20 IVD manufacturers.
• Discovery Life Sciences: Discovery Life Sciences is a major human biospecimen and clinical specimen provider with a large biobank - directly comparable to TRINA's Clinical Specimen and disease-state plasma business.
• Rockland Immunochemicals: Rockland manufactures antibodies and antigens for diagnostic and research applications - directly comparable to TRINA's Antigens & Antibodies product category.
• Innovative Research: Innovative Research supplies human plasma, serum, and specialty biological products to diagnostic and research customers - directly comparable to TRINA's core biospecimen offering.
• ZeptoMetrix (Antylia Scientific): ZeptoMetrix supplies viral antigens, plasma, serum, and disease-state biospecimens to IVD manufacturers - directly comparable to TRINA's disease-state plasma and antigen/antibody business.
• BBI Solutions (LGC Group): BBI Solutions manufactures serum, plasma, and antigens for IVD and diagnostics - directly overlaps with TRINA's serum/plasma and antigens portfolio and customer set.

Broad incumbents

• Bio-Techne (R&D Systems): Bio-Techne is a large life science tools company producing proteins, antibodies, and reagents including IVD-relevant content - overlaps with TRINA's antigen/antibody offerings within a much wider portfolio.
• MilliporeSigma (Merck KGaA Life Science): MilliporeSigma is a global life science raw materials supplier (cell culture, plasma, sera, reagents) - competes with TRINA's cell culture and serum products as part of a vastly broader catalogue.
• Surmodics: Surmodics is a larger IVD component and surface chemistry supplier to the diagnostics industry - serves overlapping IVD manufacturers with a broader reagent/component portfolio than TRINA.

Regional players

• Cambridge Bioscience: Cambridge Bioscience distributes human biospecimens, antigens, and clinical specimens in the UK/EMEA market - offers a comparable but regionally focused biospecimen catalogue to TRINA's.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/trinabio

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TRINA BIOREACTIVES